Gadopentetate dimeglumine and iodinated contrast media. Hemodynamic side effects after bolus injections in pigs.
The use of bolus injections of contrast media containing gadolinium for magnetic resonance imaging and their potential use as x-ray absorbents require the evaluation of possible cardiovascular side effects. The hemodynamic reactions of high doses (0.6 mmol/ kg) of gadopentetate dimeglumine (gadolinium [Gd]-DTPA, Magnevist) were evaluated and compared with the side effects of ionic (diatrizoate: Urografin 76%) and nonionic (iopamidol, Solutrast 370) radiographic contrast media. In 18 pigs, pressure and flow of the systemic and pulmonary circulation were monitored after intracardiac bolus injections (2-4 seconds) of dose volumes of 1.2 mL/kg of each contrast agent. All contrast media decreased the aortic pressure transiently (Gd-DTPA and diatrizoate: -25%, iopamidol: -10%; P < 0.01). Pulmonary artery pressure, cardiac output, and stroke volume increased for several minutes. The vascular resistance declined. Diatrizoate induced stronger and longer-lasting side effects (P < 0.01) than Gd-DTPA and iopamidol. Despite of similar osmolality, Gd-DTPA induced weaker side effects than equivolumetric applications of diatrizoate. Other than osmolality, other factors such as viscosity and chemotoxicity influence the side effects of contrast media.